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SUMMARY 
Background: The global prevalence of diabetes and its 
complications is increasing worldwide. Its role in coro-
nary heart disease has been linked with the presence of 
left ventricular hypertrophy (LVH). The present study 
aims to determine the prevalence of electrocardio-
graphic left ventricular hypertrophy (ECG-LVH) in 
adult diabetic subjects, its epidemiological and clinical 
correlates. 
Methods: A descriptive cross-sectional study involv-
ing 534 patients was conducted at the Edward Francis 
Small Teaching Hospital (formerly Royal Victoria 
Teaching Hospital), The Gambia. Four hundred and 
forty patients were included using a standard question-
naire. Anthropometry, laboratory investigations and 
electrocardiogram were carried out. We used the Lew-
is, Cornell, and Sokolow-Lyon Voltage criteria to de-
fine ECG-LVH. MinitabTM statistical software version 
13.20 was used for analysis. 
Results: 146 (35.2%) patients had ECG-LVH using all 
3 criteria and this prevalence was higher among wom-
en being 116 (79.5%). A generally high prevalence of 
overweight (155/37.4%) and obesity (119/28.6%) was 
observed among study participants, and both clinic-day 
systolic and diastolic blood pressure (BP) were signifi-
cantly higher in those with ECG-LVH. Poor diabetes 
control was observed in both groups. 
Conclusion: There was a high prevalence of ECG-
LVH and it is especially so with combining multiple 
criteria, hence the need for screening. Clinic-day hy-
pertension was associated with ECG-LVH hence the 
need for diagnosing and aggressive treatment of hyper-
tension in patients with diabetes mellitus. 
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The global prevalence of diabetes mellitus (DM) con-
tinues to rise at an alarming rate.1 It is acknowledged as 
a principal risk factor for cardiovascular morbidity and 
mortality and has a heavy impact on the global health 
expenditure due to both its short and long term compli-
cations.2 DM is closely linked to coronary events3 and 
left ventricular hypertrophy (LVH) in DM patients has 
been widely implicated4,5 and therefore considered as a 
treatment target5, as associated cardiovascular risks 
become normal with full regression of LVH.6  Insulin 
resistance and associated abnormal glucose metabolism 
have been implicated in many reports as a possible 
pathophysiological mechanism of LVH. This therefore 
highlights the need for the early detection of LVH in 
DM in order to institute a timely effective interven-
tion.7 
 
Electrocardiogram remains a cheap, useful and a wide-
ly available tool to determine LVH.8 This paper aims to 
determine the prevalence of electrocardiographic left 
ventricular hypertrophy (ECG-LVH) among adult 
Gambian DM patients and also to determine its associ-
ated clinical factors. 
 
METHODS 
This study was conducted at the Edward Francis Small 
Teaching Hospital (EFSTH) in Banjul, The Gambia 
during routine clinic visits (on every Monday and 
Wednesday) from the 6th November, 2008 to the 4th 
January 2009 between the hours of 8am and 2pm. 
 
Study Population: All patients with a confirmed diag-
nosis of DM and who attend the medical out-patient 
department, EFSTH for routine care were eligible for 
inclusion into the study. Pregnant women and those 
who did not consent for inclusion were excluded.  
 
 




Subjects less than 25 years of age and those with bun-
dle branch block were excluded from the present anal-
ysis. 
 
Study design: cross-sectional study. 
 
Questionnaire: a trained research field assistant in a 
language understood by the study participant adminis-
tered a standard questionnaire designed for the purpose 
of the study. The questionnaire was divided into 3 sec-
tions.  Section A included items on demographic de-
tails like age, sex, address, ethnicity, religion, educa-
tional level, smoking status as well as background de-
tails about the participant’s DM. Occupations were 
coded as manual if involving mainly unskilled labour; 
as trades for occupations mainly involving skilled 
manual labour; or as non-manual. The rest were coded 
as others.  Section B covered information about the 
usual medical care the patient receives (including activ-
ities at clinic visits, medications prescribed) and also 
evidence of diabetic foot (or feet) complication(s). Sec-
tion C involved carrying out basic anthropometric 
measurements, blood pressure (BP) measurements, 
urine dipstick, and venous blood sampling for serum 
biochemistry and also obtaining a standard 12-lead 
surface ECG. 
  
Blood pressure: Blood pressure and pulse rate were 
recorded with an Omron 705IT machine (Omron, Kyo-
to, Japan) with the participant in a seated position using 
the subject’s left arm positioned at heart level. The BP 
was taken first when the patient enters the consulting 
room and after five minutes. Two measurements were 
done at each time and the mean of the two readings 
was recorded. 
 
Anthropometry: Height was measured without foot-
wear or headwear with the subject standing fully erect 
on a flat surface, with heels, buttock and shoulders flat 
to the height meter, and the subject looking straight 
ahead using a daily calibrated stadiometer (Leicester 
height measure, Seca 214, Birmingham, UK). Meas-
urement was done to the nearest 0.5cm. Weight was 
measured with the subject wearing light clothing with 
no footwear using a digital scale (Tanita Corporation, 
Tokyo, Japan). The value was recorded to the nearest 
0.1kg. Waist circumference measured at the level of 
the upper margin of the iliac crest, was measured to the 
nearest centimeter with a flexible tape. Body mass in-
dex (BMI) was defined as weight (kg)/height (m).2 We 
used a new generation foot-to-foot bioimpedence de-
vice (Tanita TBF300GS, Tanita Corporation) to meas-
ure fat percent, fat mass, total body water (TBW) with 
the subject standing erect in bare feet on the bioim-
pedence analyzer. 
 
Blood and urine samples: Venous blood samples were 
collected and analysed using a COBAS INTEGRA 
400 plus analyser (Roche Diagnostics GmbH) at the 
EFSTH laboratories for total cholesterol, high density 
lipoprotein cholesterol (HDL-cholesterol), low density 
lipoprotein cholesterol (LDL-cholesterol), triglycer-
ides, creatinine, fructosamine, albumin and uric acid 
levels. Blood glucose was determined using a portable 
glucometer (Accu-Chek). Urine sample was also col-
lected and urine dipstick was done for glucose and pro-
tein. 
 
Electrocardiography: The study participants had a 
standard surface 12-lead ECG recorded with the patient 
lying supine and relaxed on a flat surface (using a Car-
dioline Delta 1 EKG Machine). The machine was regu-
larly checked to ensure that it was in a proper working 
condition. After explaining the procedure to the patient, 
the ECG leads were placed according to standard prac-
tice. The paper speed was set at 25mm/s whilst the 
voltage set at 10mm/mV. The ECG recordings were 
sent to Aristide Le Dantec Teaching Hospital, in Da-
kar, Senegal and analysed by a group of cardiology 
residents, supervised by an electrophysiologist with 
many years of experience using a specially designed 
protocol. The various parameters studied included the 
rhythm, heart rate, PR interval, presence of significant 
Q wave, LVH (using Lewis, Cornell, and Sokolow-
Lyon voltage criteria) and ST-T changes.  
 
ECG-LVH was defined according to standard criteria 
using the mean of 3 consecutive QRS values as fol-
lows: Lewis voltage as (R wave in lead 1-R wave in 
lead 3)+(S wave in lead 3-S wave in lead 1)≥1.7mV 
9Cornell voltage as S wave in V3+ R wave in 
aVL≥2.0mV in women and 2.8mV in men10 Sokolow-




The data of each participant was collected on a ques-
tionnaire which was then entered into Microsoft Excel 
2007 by double entry. The data was cross-checked and 
all inconsistencies were corrected. The data was then 
transferred to and analyzed using MinitabTM statistical 
software version 13.20.  The characteristics of patients 
with ECG-LVH and those without it were compared 
using two-sample t-test for continuous variables and 
Chi-square test for categorical variables.  P-values of 




The School of Medicine and Allied Health Sciences, 
University of the Gambia Research and Publication 
Committee approved the study protocol.  
 
 




An informed consent was obtained from each of the 
study participants after explanation and careful consid-
eration by the participant signing or thumbs printing a 
written consent form.  
 
RESULTS 
A total of 534 patients (171 males and 363 females) 
took part in the study, of whom 440 (131 males and 
309 females) had a standard surface ECG. Of those 
who had an ECG, 415 (121 males and 294 females) 
met criteria for inclusion in this analysis. The majority 
of participants, 80.3% were between the ages of 40 and 
69; The actual age distribution according to age groups 
(25-39, 40-54, 55-69 and ≥ 70 years) was 49 (11.8%), 
175 (42.2%), 158 (38.1%) and 33 (7.9%) respectively.  
 
The prevalence of ECG-LVH according to the different 
criteria used is shown in Table 1. The highest preva-
lence was recorded with the Cornell voltage criteria. 
With the Lewis but especially the Cornell voltage crite-
ria, where the number of females diagnosed was signif-
icantly higher than that of males. However, this large 
difference was not observed with the Sokolow-Lyon 
criteria. 
 
Table 1 Prevalence of LVH in diabetic patients accord-
ing to different ECG criteria 








Lewis 9 (7.4%) 35 (11.9%) 44 (10.6%) 0.179 
Cornell 13 (10.7%) 89 (30.3%) 102 
(24.6%) 
<0.001 
Sokolow-Lyon 15 (12.4%) 38 (12.9%) 53 (12.8%) 0.883 
Combined 
criteria 






One hundred and forty-six (35.2%) patients met one or 
more of the three standard criteria that we have used to 
define ECG-LVH, of whom 116 (79.5%) were females.  
Among the female population studied, 116 (39.5%) had 
ECG-LVH compared to 30 (24.8%) of males.  
 








Age (years) 52.9±11.1 53.1±11.5 0.910 









Height (cm) 161.9±6.9 162.7±8.8 0.352 
Weight (Kg) 73.3±13.9 72.4±15.2 0.564 
BMI (kg/m²) 28.0±5.2 27.4±6.1 0.352 
History of hypertension 97 (66.4%) 152 (56.5%) 0.056 
Systolic BP(mmHg) 137.5±22.5 129.8±21.3 0.001 
Diastolic BP(mmHg) 80.3±12 76.5±9.5 < 0.001 
BMI- body mass index, BP- blood pressure 
 
As shown in Table 2, there was no significant differ-
ence in the age of patients with or without ECG-LVH 
both at the time of diagnosis of diabetes and also at the 
time of the study.  
 
Hypertension was more prevalent among subjects with 
ECG-LVH but this was not statistically significant. 
However, clinic-day systolic and diastolic BPs were 
significantly more elevated among patients with ECG-
LVH.  
 
Two hundred and seventy-four (66%) of patients were 
either overweight (155/37.4%) or obese (119/28.6%). 
We found a significant difference between the sexes as 
48 (39.7%) and 9 (7.4%) of males were respectively 
overweight and obese compared to 107 (36.4%) and 
110 (37.4%) of females (P<0.001); indeed the distribu-
tion of subjects by BMI (<18.5, 18.5-24.9, 25-29.9 and 
≥30) was 9 (2.2%), 132 (31.8%), 155 (37.3%) and 119 
(28.7%) respectively.  
 
However, as shown in Table 3 there was no significant 
statistical difference between BMIs of subjects with or 
without ECG-LVH.  Serum creatinine and lipid profile 
were similar in both groups. However, serum albumin 
level was significantly lower among patients with 
ECG-LVH. In this cohort, fructosamine levels were 
high in both groups.  
 
















































Results are shown as mean and 95% CI  
 
DISCUSSION 
The prevalence of ECG-LVH using all three standard 
criteria (Lewis, Cornell and Sokolow-Lyon Voltage) in 
this study was high (35.2%). The prevalence was high-
er in females compared to males using either all or any 
of the aforementioned criteria. Using the individual 
criteria, the prevalence of ECG-LVH was highest with 
the Cornell voltage criteria (26.8%) and lowest with the 








It has been demonstrated from previous studies that 
ECG has a lower sensitivity compared to echocardiog-
raphy in determining LVH.12 Generally, black individ-
uals have greater precordial QRS voltages than whites 
and many of the LVH criteria have higher sensitivity in 
detecting LVH in blacks and lower specificity com-
pared with whites.13,14 However, many of the criteria 
proposed like the Araoye for African blacks are yet to 
be validated and so far have offered no comparative 
advantage over the standard criteria.15  
 
Additionally many factors might limit the accuracy of 
ECG in determining LVH including age, body habitus, 
obesity and chronic lung diseases.  Hence many au-
thors advocate the use of echocardiography to deter-
mine LVH.  However, the availability of echocardiog-
raphy is still limited and not feasible in many places 
especially in our sub-region. Besides the unavailability 
of technical expertise to operate echocardiography in 
many places, high costs further limits its usage. The 
present study compared different voltage criteria and 
showed the superiority of using more than one criterion 
to determine ECG-LVH. This is advocated by many 
authors and has been demonstrated in various stud-
ies.16,17,18 
  
We found in the present study that both systolic and 
diastolic BP were significantly higher in those with 
ECG-LVH which is consistent with the findings by 
Desai et al19, There is therefore the need for a more 
aggressive BP control.  Niiranen et al found home 
measured blood pressure values to be more strongly 
associated with ECG-LVH.20 In the Cascale Monferra-
to study however, the prevalence of hypertension was 
high and systolic BP were raised in both groups (i.e. 
those with ECG-LVH and those without) but with no 
statistical difference. 6 
 
There is paucity of data regarding the relationship be-
tween low serum albumin level and LVH in DM pa-
tients which we found in our study. This needs evalua-
tion with further studies as low serum albumin has 
been strongly linked to cardiovascular events in a pre-
vious study.21 
 
We used fructosamine to assess glycaemic control 
which we found to be poor in both groups but with no 
significant difference. This finding is similar to that in 
the Cascale Monferrato study where glycated hemo-
globin was used as a marker for glycaemic control.6 
There was a high prevalence among study participants 
of overweight and obesity. This is consistent with the 
findings in a previous study in urban Gambia.22 This, 
and the poor metabolic control are risks for cardiovas-
cular complications and hence require effective inter-
vention.  
Women with DM have been shown to have a higher 
cardiovascular morbidity and mortality than their male 
counterparts.23, 24, 25 Therefore the higher prevalence of 
females with LVH and obesity in this cohort is worry-
ing and needs attention.  
 
We advocate for the early detection and aggressive 
treatment of LVH to prevent potentially life-
threatening consequences. Many antihypertensive 
agents have been recommended for the treatment of 
LVH. However, agents with intrinsic sympathomimetic 
properties or with direct vasodilatory effects (e.g. hy-
dralazine and minoxidil) must be avoided.26 The most 
effective agents in reducing left ventricular mass are 
angiotensin II receptor blockers, angiotensin-
converting enzyme inhibitor, calcium channel blockers 
and diuretics.27 Bauml and Underwood recommend 
that treatment should consist of an angiotensin II recep-
tor blocker or an angiotensin-converting enzyme inhib-
itor 28 which have additional renoprotective effect as 
well as reversing LVH. However, these agents are less 
efficacious in blacks according to the investigators of 
Studies of Left Ventricular Dysfunction (SOLVED) 29 
but who have been shown to benefit from treatment 
with diuretic agents.26  
 
CONCLUSION 
We found a higher prevalence using multiple criteria to 
determine ECG-LVH and this prevalence was higher 
among females and associated with high clinic-BP. 
Therefore, screening, aggressive treatment for ECG-
LVH and associated high BP should be instituted in the 
standard care of DM patients.  
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